India's Pharmaceutical Exports

Country Profile

Germany

Germany is a major destination for Indian pharmaceutical exports — $634M in FY 2025–26, with 2.0× growth over the past decade. Medicines accounts for 63% of shipments. The compound annual growth rate since FY2015 stands at 6.4%.

🇩🇪 #6 Destination · $634M · 2.0× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$634M
Exports FY2025–26 DGCIS
2.0×
Growth FY2015→2026
2.0%
Share of India Total
#6
Rank Among 178 Markets
6.4%
CAGR FY2015→2026
Germany is a major destination for Indian pharmaceutical exports — $634M in FY 2025–26, with 2.0× growth over the past decade. Medicines accounts for 63% of shipments. The compound annual growth rate since FY2015 stands at 6.4%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $397M (62.5%) Medicine Ingredients $137M (21.6%) Traditional & Herbal $64.3M (10.1%) Surgical & Hospital Supplies $36.1M (5.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Germany in the RBI overseas direct investment dataset (2011–2026).